Browsing by Author/Editor/Contributor VERBEECK, Johan

Jump to a point in the index:
Showing results 1 to 20 of 47  next >
Issue DateTitleAuthor(s)TypeCat.
2026Towards patient-centred benefit-risk assessment with generalised pairwise comparisonsVERBEECK, Johan Journal ContributionA2
2025Reflection on clinical and methodological issues in rare disease clinical trialsVERBEECK, Johan ; Geroldinger, Martin; Nyberg, Joakim; Thiel, Konstantin E.; Hooker, Andrew C.; Bathke, Arne C.; Bauer, Johann W.; Laimer, Martin; MOLENBERGHS, Geert ; Zimmermann, GeorgJournal ContributionA1
2025An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European UnionLOEDY, Neil ; Dorta, Hector G.; ABRAMS, Steven ; CREVECOEUR, Jonas ; Morales, Daniel R.; Cohet, Catherine; WILLEM, Lander ; MOLENBERGHS, Geert ; HENS, Niel ; Kurz, Xavier; Quinten, Chantal; VERBEECK, Johan Journal ContributionA1
2025Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based studyGonzalez Dorta, Hector; VERBEECK, Johan ; CREVECOEUR, Jonas ; Morales, Daniel; LOEDY, Neil ; Cohet, Catherine; Willem , Lander; MOLENBERGHS, Geert ; HENS, Niel ; Kurz, Xavier; Quinten, Chantal; ABRAMS, Steven Journal ContributionA1
2025Rationale and Design of the DECONGEST (Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment) StudyVanhentenrijk, S; VERBEECK, Johan ; Kalpakos, T; Vandoren, Vincent; Braeckeveldt, L; L'Hoyes, W; Choustoulakis, E; Roosens, B; Tang, WHW; VERWERFT, Jan ; VERBRUGGE, Frederik Journal ContributionA1
2025From non-inferiority to superiority: the shift towards patient-centric outcomesVERBEECK, Johan ; De Backer, Mickael; BUYSE, Marc Journal ContributionA2
2025Dravet syndrome: Insights into seizure and speech progression from registry dataDelporte, Margaux; VERBEECK, Johan ; Brambilla, Isabella; Zimmermann, Georg; MOLENBERGHS, Geert ; Nabbout, RimaJournal ContributionA1
2025Effect of targeted education of patients with atrial fibrillation on unplanned cardiovascular outcomes: results of the multicentre randomized AF-EduCare trialDESTEGHE, Lien ; DELESIE, Michiel ; KNAEPEN, Lieselotte ; ONDER, Rana ; VERBEECK, Johan ; DENDALE, Paul ; Phlips, Thomas; Saenen, Johan; Haemers , Peter; Ector, Joris; VIJGEN, Johan ; HEIDBUCHEL, Hein Journal ContributionA1
2025Exercise Echocardiography for Risk Stratification in Unexplained Dyspnea: The Incremental Value of the Mean Pulmonary Artery Pressure/SlopeFALTER, Maarten ; BEKHUIS, Youri ; L'Hoyes, Wouter; MILANI, Mauricio ; HOEDEMAKERS, Sarah ; Soens, Lucie; MOURA FERREIRA, Sara ; DHONT, Sebastiaan ; PAUWELS, Rik ; Jacobs , Annemie; De Schutter, Stephanie; DELPIRE, Boris ; VERBEECK, Johan ; STASSEN, Jan ; Gevaert, Andreas B.; Debonnaire, Philippe; van de Bruaene, Alexander; BERTRAND, Philippe ; HERBOTS, Lieven ; Jasaityte, Ruta; VERBRUGGE, Frederik ; CLAESSEN, Guido ; VERWERFT, Jan Journal ContributionA1
2024Multi-stakeholder sessions on major innovation topics in rare disease clinical trialsBodden, Daniel; Schoenen, Stefanie; Wied, Stephanie; VERBEECK, Johan ; Dirani, Maya; Daya, Hiba Abou; Heussen, Nicole; MOLENBERGHS, Geert ; Hilgers, Ralf-Dieter; Nabbout, RimaJournal ContributionA1
2024Rethinking survival analysis: advancing beyond the hazard ratio?VERBEECK, Johan ; Saad, Everardo D.Journal ContributionA1
2024Enhancing robustness in acute cardiovascular observational studies: evaluating covariate adjustmentVERBEECK, Johan Journal ContributionA1
2024Evaluating the direct effect of vaccination and non-pharmaceutical interventions during the COVID-19 pandemic in EuropeFAJGENBLAT, Maxime ; MOLENBERGHS, Geert ; VERBEECK, Johan ; WILLEM, Lander ; CREVECOEUR, Jonas ; FAES, Christel ; HENS, Niel ; Deboosere, Patrick; VERBEKE, Geert ; NEYENS, Thomas Journal ContributionA1
2024Optimizing designs in clinical trials with an application in treatment of Epidermolysis bullosa simplex, a rare genetic skin diseaseNyberg, Joakim; Hooker, Andrew C.; Zimmermann, Georg; VERBEECK, Johan ; Geroldinger, Martin; Thiel, Konstantin Emil; Laimer, Martin; MOLENBERGHS, Geert ; Wally, VerenaJournal ContributionA1
2024Unraveling the impact of the COVID-19 pandemic on the mortality trends in Belgium between 2020-2022NATALIA, Yessika ; VERBEECK, Johan ; FAES, Christel ; NEYENS, Thomas ; MOLENBERGHS, Geert Journal ContributionA1
2024The impact of allocation bias on test decisions in clinical trials with multiple endpoints using multiple testing strategiesSchoenen, Stefanie; Heussen, Nicole; VERBEECK, Johan ; Hilgers, Ralf-DieterJournal ContributionA1
2024A neutral comparison of statistical methods for analyzing longitudinally measured ordinal outcomes in rare diseasesGeroldinger, Martin; VERBEECK, Johan ; Thiel, Konstantin E.; MOLENBERGHS, Geert ; Bathke, Arne C.; Laimer, Martin; Zimmermann, GeorgJournal ContributionA1
2024Covariate-adjusted generalized pairwise comparisons in small samplesJASPERS, Stijn ; VERBEECK, Johan ; THAS, Olivier Journal ContributionA1
2024Acoramidis in Transthyretin Amyloid CardiomyopathyVERBEECK, Johan ; De Backer, Mickael; BUYSE, Marc Journal ContributionA1
2024Istore: a project on innovative statistical methodologies to improve rare diseases clinical trials in limited populationsSchoenen, Stefanie; VERBEECK, Johan ; Koletzko, Lukas; Brambilla, Isabella; Kuchenbuch, Mathieu; Dirani, Maya; Zimmermann, Georg; Dette, Holger; Hilgers, Ralf-Dieter; MOLENBERGHS, Geert ; Nabbout, RimaJournal ContributionA1
Showing results 1 to 20 of 47  next >